XWELL Management

Management criteria checks 2/4

XWELL's CEO is Scott Milford, appointed in Jan 2022, has a tenure of 1.92 years. total yearly compensation is $1.25M, comprised of 33.2% salary and 66.8% bonuses, including company stock and options. directly owns 0.049% of the company’s shares, worth €3.27K. The average tenure of the management team and the board of directors is 2.2 years and 3.8 years respectively.

Key information

Scott Milford

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage	33.2%
CEO tenure	1.9yrs
CEO ownership	0.05%
Management average tenure	2.2yrs
Board average tenure	3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Scott Milford's remuneration changed compared to XWELL's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	-US$32m
Mar 31 2023	n/a	n/a	-US$34m
Dec 31 2022	US$1m	US$413k	-US$33m
Sep 30 2022	n/a	n/a	-US$16m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	US$122k
Dec 31 2021	US$1m	US$350k	US$3m
Sep 30 2021	n/a	n/a	-US$16m
Jun 30 2021	n/a	n/a	-US$27m
Mar 31 2021	n/a	n/a	-US$82m
Dec 31 2020	US$630k	US$280k	-US$91m
Sep 30 2020	n/a	n/a	-US$83m
Jun 30 2020	n/a	n/a	-US$82m
Mar 31 2020	n/a	n/a	-US$29m
Dec 31 2019	US$128k	US$128k	-US$21m

Compensation vs Market: Scott's total compensation ($USD1.25M) is above average for companies of similar size in the German market ($USD427.28K).

Compensation vs Earnings: Scott's compensation has increased whilst the company is unprofitable.

CEO

Scott Milford (59 yo)

1.9yrs

Tenure

US$1,246,956

Compensation

Mr. Scott R. Milford serves as President & Chief Executive Officer of XWELL, Inc. (formerly known as XpresSpa Group, Inc.) since January 19, 2022 and serves as Director since January 19, 2022. He served as...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Scott Milford	President	1.9yrs	US$1.25m	0.049% € 3.3k
Ezra Ernst	Executive Vice President	1.9yrs	US$688.33k	0.093% € 6.2k
Omar Haynes	VP of Treasury & Finance	2.5yrs	US$454.40k	0.026% € 1.7k
Suzanne Scrabis	Chief Financial Officer	less than a year	no data	0.11% € 7.3k
David Kohel	Chief Technology Officer	3yrs	no data	no data
Cara Soffer	Senior VP & General Counsel	2.9yrs	no data	no data
Pablo Henderson	Chief Marketing Officer	no data	no data	no data

2.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: V9G0's management team is considered experienced (2.2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Scott Milford	President	1.9yrs	US$1.25m	0.049% € 3.3k
Robert Weinstein	Independent Director	3.8yrs	US$177.01k	0.19% € 12.4k
Donald Stout	Independent Director	11.4yrs	US$127.01k	0.19% € 12.7k
Bruce Bernstein	Independent Chairman of the Board	7.8yrs	US$424.02k	0.93% € 61.9k
Michael Lebowitz	Independent Director	3.7yrs	US$147.01k	0.31% € 20.6k

3.8yrs

Average Tenure

60yo

Average Age

Experienced Board: V9G0's board of directors are considered experienced (3.8 years average tenure).

XWELL Management

Management criteria checks 2/4

Key information

Recent management updates

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee

XWELL, Inc. Announces Board Changes, Effective January 1, 2024

XWELL, Inc., Annual General Meeting, Aug 22, 2023

XWELL, Inc. Announces Executive Changes, Effective July 10, 2023

Recent updates

XWELL, Inc. to Report Q3, 2024 Results on Nov 14, 2024

XWELL, Inc. Announces Executive Changes

XWELL, Inc., Annual General Meeting, Sep 20, 2024

CPC Decides to Withdraw Lawsuit Against XWELL

XWELL, Inc. has completed a Follow-on Equity Offering in the amount of $1.422897 million.

XWELL, Inc. has filed a Follow-on Equity Offering in the amount of $1.422897 million.

CPC Pain & Wellness SPV Files Complaint in the Delaware Court of Chancery Against XWELL

CPC Pain & Wellness SPV Engages in Discussions with XWELL

XWELL, Inc. Introduces New Esthetic Facial Services to Naples Wax Center Locations

XWELL, Inc. Plans to Introduce the Ceragem V6 Therapeutic Thermal Massager in Select Xpresspa Locations

XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport

XWELL, Inc. to Report Fiscal Year 2023 Results on Apr 16, 2024

XWELL, Inc. announced delayed amended 10-K filing

XWELL, Inc. announced delayed annual 10-K filing

XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee

XWELL, Inc. Announces Board Changes, Effective January 1, 2024

XWELL, Inc. Introduces Clockwork Robotic Manicures At Harry Reid International Airport in Las Vegas

XWELL, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023

XWELL, Inc. Announces 1-for-20 Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

XWELL, Inc. (NasdaqCM:XWEL) acquired Naples Wax Center, Inc.

New major risk - Share price stability

Second quarter 2023 earnings released: US$0.069 loss per share (vs US$0.083 loss in 2Q 2022)

XWELL, Inc. to Report Q2, 2023 Results on Aug 14, 2023

XWELL, Inc., Annual General Meeting, Aug 22, 2023

Xpresspa Debuts Clockwork Robotic Manicures At Miami International Airport

New major risk - Share price stability

XWELL, Inc. Announces Executive Changes, Effective July 10, 2023

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.042 loss in 1Q 2022)

XWELL, Inc. to Report Q1, 2023 Results on May 15, 2023

XWELL, Inc. Names Valerie Lightfoot Chief Financial Officer

Full year 2022 earnings released: US$0.35 loss per share (vs US$0.032 profit in FY 2021)

Third quarter 2022 earnings released: US$0.076 loss per share (vs US$0.053 profit in 3Q 2021)

XWELL, Inc. Announces Impairment Charges for the Three Months Ended September 30, 2022

XWELL, Inc. to Report Q3, 2022 Results on Nov 10, 2022

XWELL, Inc. Receives Non-Compliance Letter from the Nasdaq

XpresSpa Group, Inc. Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

XpresSpa Group, Inc., Annual General Meeting, Oct 04, 2022

XpresSpa Group Announces the Re-Opening of XpresSpa™ Location At John F. Kennedy International Airport’s Terminal 4

XpresSpa Group, Inc. to Report Q2, 2022 Results on Aug 15, 2022

XpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry

XpresSpa Group, Inc. Revises Revenue Guidance for the Year 2022

First quarter 2022 earnings released: US$0.042 loss per share (vs US$0.01 loss in 1Q 2021)

XpresSpa Group, Inc. to Report Q1, 2022 Results on May 16, 2022

Xpresspa Group, Inc. Announces Travel Health and Wellness Brand Treat™ Launches At Phoenix Sky Harbor International Airport

XpresSpa Group, Inc. Announces the Addition of Five New Xpresspa Locations in Istanbul

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

XpresSpa Group, Inc. Announces Resignation of Douglas Satzman as President

XpresSpa Group, Inc. (NasdaqCM:XSPA) entered into an acquisition agreement to acquire Gcg Connect Llc.

Independent Chairman of the Board recently bought €57k worth of stock

Forecast to breakeven in 2022

Third quarter 2021 earnings released: EPS US$0.053 (vs US$0.10 loss in 3Q 2020)

Independent Chairman of the Board recently bought €131k worth of stock

Forecast to breakeven in 2022

First quarter 2021 earnings released: US$0.01 loss per share (vs US$1.74 loss in 1Q 2020)

Full year 2020 earnings released: US$2.03 loss per share (vs US$12.99 loss in FY 2019)

Xpresspa Group Signs Contract with Port of Seattle for an Xprescheck™ Covid-19 Pop-Up Testing Facility At Seattle-Tacoma International Airport

XpresSpa Group Signs Contract with Metropolitan Washington Airports Authority for XpresCheck™ COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport

New 90-day high: €2.34

New 90-day high: €1.98

XpresSpa Group Announces New Collaboration with JetBlue Airlines at Boston Logan International Airport for both Rapid and PCR COVID-19 Testing

Xpresspa Group, Inc Announces Partnership with United Airlines for Covid-19 Testing with Xprescheck Testing Facilities

New 90-day low: €1.08

XpresSpa Group, Inc Appoints James Berry as Chief Financial Officer, Effective December 14, 2020

XpresSpa Group, Inc. Announces David Kohel as Its Chief Technology Officer

New 90-day low: €1.40

XpresSpa Group, Inc. to Report Q3, 2020 Results on Nov 16, 2020

XpresSpa Group, Inc. Announces Expansion of Health and Wellness Services Beyond COVID-19 Testing

XpresSpa Group, Inc. Provides Business Update on XpresCheck™